Goldman Sachs lowered the firm’s price target on Axon (AXON) to $535 from $625 and keeps a Buy rating on the shares. Axon demonstrates continued evidence of its business diversifying beyond its core domestic state & local law enforcement customer base, and traditional products, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON:
- Axon price target lowered to $674 from $690 at Piper Sandler
- Axon price target raised to $755 from $750 at JPMorgan
- Axon Earns Buy Rating on Robust ARR Growth, AI-Driven Demand, and Underappreciated Profitability
- Axon price target lowered to $675 from $800 at Baird
- Axon price target lowered to $440 from $570 at UBS